Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
about
Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospitalOccupational exposure to chemotherapy of pharmacy personnel at a single centreA study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.Occupational exposure to cytotoxic drugs in two UK oncology wards.Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry.Biomonitoring of occupational exposures to cytostatic anticancer drugs.Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.Prevention of the exposure by cyclophosphamide oral tablet.Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces.Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination.Contamination of syringe plungers during the sampling of cyclophosphamide solutions.Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan.
P2860
Q28384936-0C2E5B92-4CBE-4A97-A06A-7245E98C768CQ28392801-CFEF843A-4510-4E62-B6BE-0992D7B99562Q33857689-7B34B69F-CA4E-4BE5-9625-B0BAF25C94F0Q35496593-5CAD15BC-6A12-436B-9D59-01DCFC004F31Q40024426-D361C901-66AC-4A67-BF36-BC32A53DBAE5Q41453490-F9030634-AB80-489E-9CFD-284014CC8364Q42583436-87971DC3-5033-4F97-953E-F403C481CC5AQ43066266-EDD42737-630B-42D3-B589-64BB28F95AC7Q43713519-7FA5B846-82F5-4CB8-B91F-23EFFA53BDC7Q44802357-B7BED770-C246-42DA-9EEA-21B847FACADDQ45165360-04799294-4371-43B7-93EC-6EA849A5D6D1Q46458214-26FAD578-E3A3-44C4-BFD5-1802485901F0Q51276179-C5DB40B2-D72E-47ED-8328-9F5C1FBAEBC8Q51771056-C5168C96-7756-4FD7-80D4-4419ED690A5B
P2860
Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@ast
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@en
type
label
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@ast
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@en
prefLabel
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@ast
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@en
P2093
P2860
P356
P1476
Biological monitoring of cyclo ...... y exposed to cytostatic drugs.
@en
P2093
P2860
P304
P356
10.1136/OEM.51.4.229
P577
1994-04-01T00:00:00Z